EV71 vaccine study for Vietnamese children
Part of Infections clinical trials.
This study tests an EV71 vaccine in healthy children aged 6 to 71 months. The vaccine aims to protect against hand, foot, and mouth disease caused by the EV71 virus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 months and 5 years old (up to 5 years and 11 months) at the time of the first dose.
- Your child must be generally healthy and not have had hand, foot, and mouth disease before.
- You (the guardian) must be able to understand and sign a consent form, and your child must be able to follow study procedures.
- Your child should not have a known allergy to vaccines or vaccine ingredients, and no history of immune system problems, like autoimmune diseases or HIV.
- Your child should not have recently taken certain medications (like immunosuppressants) or received blood products or other vaccines within the specified timeframes.
- Your child should not have a fever (37.5°C or higher) on the day of vaccination, and no recent acute illness or exposure to someone with HFMD within 2 weeks before enrollment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new two-in-one vaccine to protect children against hand, foot, and mouth disease caused by two common viruses (EV71 and CA16). It is for healthy kids ages 6 months to 5 years and will check if the vaccine is safe and works well.
This study checks how long immunity lasts after receiving two doses of the EV71 vaccine. It is for children who took part in the earlier study and got either the vaccine or a placebo.
This study tests a new vaccine that protects against four types of enterovirus (EV71, CA16, CA10, CA6) that cause hand, foot, and mouth disease. Researchers want to see if the vaccine is safe and effective in young children ages 6 months to 6 years.
This trial tests a vaccine that targets two viruses causing hand, foot, and mouth disease. It aims to see if the vaccine is safe and effective for people aged 6 months to 59 years.
This study tracks how respiratory syncytial virus (RSV)—a common respiratory infection in babies—affects children under 24 months in Ho Chi Minh City. Researchers want to understand how often RSV happens, how severe it is, and how it impacts families, so they can better prepare healthcare services.
This study tests three batches of an EV71 vaccine (which prevents hand, foot, and mouth disease) to see if they work the same. Your child would receive two doses, several weeks apart, and have blood tests to check their immune response.
Hear when a new Hand, Foot, and Mouth Disease (HFMD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.